Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva M Weissinger

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
Leukemia|October 21, 2020
A multicenter prospective, randomized, placebo-controlled phase II/III trial for preemptive acute graft-versus-host disease therapyEva M Weissinger, Jochen Metzger, Michael Schleuning, et al.
The Lancet. Oncology|April 7, 2009
Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II studyFabio Ciceri, Chiara Bonini, Maria Teresa Lupo Stanghellini, et al.
Molecular & Cellular Proteomics : MCP|July 10, 2010
Naturally occurring human urinary peptides for use in diagnosis of chronic kidney diseaseDavid M Good, Petra Zürbig, Angel Argilés, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
Leukemia|October 21, 2020
A multicenter prospective, randomized, placebo-controlled phase II/III trial for preemptive acute graft-versus-host disease therapyEva M Weissinger, Jochen Metzger, Michael Schleuning, et al.
The Lancet. Oncology|April 7, 2009
Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II studyFabio Ciceri, Chiara Bonini, Maria Teresa Lupo Stanghellini, et al.
Molecular & Cellular Proteomics : MCP|July 10, 2010
Naturally occurring human urinary peptides for use in diagnosis of chronic kidney diseaseDavid M Good, Petra Zürbig, Angel Argilés, et al.
Pageof 6